University of Chicago Nephrology

Topics

• Renal Transplantation Outcomes and Treatments 314
• Parathyroid Disorders and Treatments 283
• Organ Transplantation Techniques and Outcomes 249
• Mechanical Circulatory Support Devices 244
• Kidney Stones and Urolithiasis Treatments 222
• Genetic and Kidney Cyst Diseases 181
• Liver Disease Diagnosis and Treatment 180
• Acute Kidney Injury Research 156
• Hepatitis C virus research 114
• Pancreatic function and diabetes 113
• Renal Diseases and Glomerulopathies 103
• Pregnancy and preeclampsia studies 98

Most cited

1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

   Journal of hepatology · 2023 · 2,696 citations · Mary Rinella

2. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.

   Hepatology (Baltimore, Md.) · 2023 · 2,397 citations · Mary Rinella

3. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.

   The New England journal of medicine · 2024 · 1,637 citations · Mary Rinella

4. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.

   Hepatology (Baltimore, Md.) · 2023 · 2,087 citations · Mary Rinella

5. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.

   The New England journal of medicine · 2025 · 750 citations · Mary Rinella

6. Non-alcoholic fatty liver disease.

   Lancet (London, England) · 2021 · 2,293 citations · Mary Rinella

7. A multisociety Delphi consensus statement on new fatty liver disease nomenclature.